Helius Medical Technologies Inc (HSDT) Stock Price, Quote & News

Company Profile

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in c...

Industry: Medical Devices

Sector: Healthcare

Phone: 215 944 6100

Website: heliusmedical.com

Address:

642 Newtown Yardley Road, Suite 100, Newtown, United States

Hassan77 Aug. 5 at 8:32 PM

$HSDT Finally hit $5 today. Now the real games begin…they cannot keep tanking the price without an offering or bad news. I think MAX MAX pain here is in the upper $4 range but we will see soon what these crooks are planning. If it does pump again im getting out PM…these fuckers love to trap.

1 · Reply

DXTR_Investor Aug. 5 at 8:01 PM

$HSDT added 200 more shares to average down. Not a lot, just trying to accumulate this company shares before the big jump! 😊

0 · Reply

Skypier2 Aug. 5 at 7:45 PM

$BINI $HSDT

0 · Reply

Crackberry Aug. 5 at 7:42 PM

$HSDT look at this crazy wide spread

1 · Reply

Crackberry Aug. 5 at 7:28 PM

$HSDT major manipulation going on. Know that FDA data read out and FDA fast track submission is this month. Very wide spread

1 · Reply

Lay1a Aug. 5 at 7:24 PM

$HSDT Yup $5S are here and next week $4S. I try to warn you guys no PR until Sept or Oct. It will slowly bleed 10% per week.

0 · Reply

ShadowSnake Aug. 5 at 7:13 PM

$HSDT POS

0 · Reply

Got1me99 Aug. 5 at 6:52 PM

$HSDT there goes $6 welppppp🤨 going down with this POS ship at this point 😂🤡

0 · Reply

Binayakbasnet0 Aug. 5 at 6:35 PM

$HSDT Funny how the loudest voices are always the ones who missed the first move. 'No one wants to buy'? $6 is a discount if you're playing the squeeze game, not scared money. Retail’s shaken, but institutions don’t tweet—they load. HSDT has FDA catalysts, short interest pressure, and history of Monday PRs. If it does what $TNON did, $6 will look like a dream entry. People waiting for $2 will be watching from the sidelines when $20 flashes in premarket. Bulls accumulate fear. Bears post tweets. Choose your side wisely.

1 · Reply

Lay1a Aug. 5 at 4:49 PM

$HSDT No one wants to buy this POS even at $6. Buyers are waiting in the $2-$3 range. I smell an offering if it drops under $3 as tutes want it as cheap as possible before buying.

0 · Reply

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation

Jul 9, 2025, 8:30 AM EDT - 27 days ago

Helius Medical Technologies, Inc. Compliant with Nasdaq's Continued Listing Requirements

Jul 8, 2025, 8:01 AM EDT - 4 weeks ago

Helius Medical Technologies, Sunrun And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

RUN

Jun 27, 2025, 8:30 AM EDT - 5 weeks ago

Helius Medical Technologies Announces Reverse Stock Split

Jun 16, 2025, 7:00 AM EDT - 7 weeks ago

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device

Jun 12, 2025, 7:00 AM EDT - 7 weeks ago

Positive PoNSTEP Study Results Presented at Consortium of Multiple Sclerosis Centers Annual Meeting

Jun 11, 2025, 7:00 AM EDT - 7 weeks ago

Helius Medical Technologies, Inc. Announces Authorized Claim for Payment by Major Healthcare Payer for its Portable Neuromodulation Stimulator (PoNS®) Device

Jun 4, 2025, 9:12 PM EDT - 2 months ago

Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering

Jun 4, 2025, 7:00 AM EDT - 2 months ago

Helius Medical Technologies, Inc. Compliant with Nasdaq Bid Price Rule Listing Criteria

May 20, 2025, 7:00 AM EDT - 2 months ago

Helius to Spotlight Study Confirming Improved Long-Term Outcomes from Adherence to PoNS Therapy® at CMSC Annual Meeting

May 12, 2025, 7:00 AM EDT - 3 months ago

Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Mar 13, 2025, 7:00 AM EDT - 5 months ago

Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary

Mar 11, 2025, 7:00 AM EDT - 5 months ago

Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device

Jan 22, 2025, 7:00 AM EST - 6 months ago

Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study

Jan 21, 2025, 8:00 PM EST - 7 months ago

Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market

Dec 23, 2024, 7:00 AM EST - 8 months ago

Helius Announces First Portable Neuromodulation Stimulator (PoNS®) System Sale to the Veterans Affairs (VA) Healthcare System

Nov 18, 2024, 8:01 AM EST - 9 months ago

Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) Device

Oct 14, 2024, 5:00 PM EDT - 10 months ago

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

Aug 16, 2024, 5:00 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Aug 12, 2024, 9:33 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports Second Quarter 2024 Financial Results

Aug 6, 2024, 4:36 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Second Quarter 2024 Financial Results on August 12, 2024

Jun 17, 2024, 7:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke

May 31, 2024, 12:30 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Present at the Spring MicroCap Rodeo Conference

May 23, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies to Exhibit at 2024 CMSC Annual Meeting, Marking a Year of Achievements: Making PoNS More Available to People with MS

May 20, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces PoNS® Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts

May 13, 2024, 7:21 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports First Quarter 2024 Financial Results

May 10, 2024, 9:00 AM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release First Quarter 2024 Financial Results on May 13, 2024

May 6, 2024, 10:15 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering

Apr 24, 2024, 9:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Expands Stroke Clinical Program with Participation of Shepherd Center

Apr 3, 2024, 7:55 AM EDT - 1 year ago

Helius Medical stock rallies 40%: explore why

Apr 3, 2024, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Announces Partnership with Lovell® Government Services to Expand Reach of PoNS Therapy™

Mar 28, 2024, 8:45 PM EDT - 1 year ago

Helius Medical Technologies, Inc. (HSDT) Q4 2023 Earnings Call Transcript

Mar 28, 2024, 4:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 15, 2024, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024

Mar 12, 2024, 8:59 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Initiates Open-Label Study for Registrational Program in Stroke

Mar 7, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. to Present at the 36th Annual ROTH Conference

Mar 4, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller

Feb 6, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients

Feb 5, 2024, 7:05 AM EST - 1 year ago

Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists' Ability to Customize PoNS Therapy® to Improve Gait in People with MS

Jan 11, 2024, 7:00 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital

Nov 30, 2023, 7:47 AM EST - 1 year ago

Helius Medical Technologies to Present at NobleCon19 Annual Conference

Nov 12, 2023, 8:11 AM EST - 1 year ago

Helius Medical Technologies, Inc (HSDT) Q3 2023 Earnings Call Transcript

Nov 6, 2023, 7:05 AM EST - 1 year ago

Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work

Nov 2, 2023, 5:05 PM EDT - 1 year ago

Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024

Oct 12, 2023, 7:05 AM EDT - 1 year ago

Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices

Oct 2, 2023, 7:05 AM EDT - 2 years ago

Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences

Sep 28, 2023, 7:00 AM EDT - 2 years ago

Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece

Sep 21, 2023, 7:05 AM EDT - 2 years ago

Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference

Hassan77 Aug. 5 at 8:32 PM

1 · Reply

DXTR_Investor Aug. 5 at 8:01 PM

$HSDT added 200 more shares to average down. Not a lot, just trying to accumulate this company shares before the big jump! 😊

0 · Reply

Skypier2 Aug. 5 at 7:45 PM

$BINI $HSDT

0 · Reply

Crackberry Aug. 5 at 7:42 PM

$HSDT look at this crazy wide spread

1 · Reply

Crackberry Aug. 5 at 7:28 PM

$HSDT major manipulation going on. Know that FDA data read out and FDA fast track submission is this month. Very wide spread

1 · Reply

Lay1a Aug. 5 at 7:24 PM

$HSDT Yup $5S are here and next week $4S. I try to warn you guys no PR until Sept or Oct. It will slowly bleed 10% per week.

0 · Reply

ShadowSnake Aug. 5 at 7:13 PM

$HSDT POS

0 · Reply

Got1me99 Aug. 5 at 6:52 PM

$HSDT there goes $6 welppppp🤨 going down with this POS ship at this point 😂🤡

0 · Reply

Binayakbasnet0 Aug. 5 at 6:35 PM

1 · Reply

Lay1a Aug. 5 at 4:49 PM

$HSDT No one wants to buy this POS even at $6. Buyers are waiting in the $2-$3 range. I smell an offering if it drops under $3 as tutes want it as cheap as possible before buying.

0 · Reply

AG1011 Aug. 5 at 1:00 AM

$HSDT people are sleeping on this

1 · Reply

Lay1a Aug. 4 at 11:43 PM

$HSDT I've said it a few times. News will probably come in Sept or Oct. By then expect the share price to bleed down between $2 - $3. Mark this post.

2 · Reply

Crackberry Aug. 4 at 10:51 PM

$HSDT when this will have a $PBM and $VERB type move, then they'll chase. Allows stroke patients to walk again by using a modified proprietary electric tongue depressor

0 · Reply

Crackberry Aug. 4 at 8:39 PM

$HSDT RELEASE THE FKN NEWS!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! DAMMMMMIT

1 · Reply

DXTR_Investor Aug. 4 at 8:23 PM

$HSDT Traded well below their cash holding and has no debt. I am taking my chances in this company with several catalysts that could propel the share price much higher than the current level. One of them with their latest report of Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation during this quarter (July-September) and hoping to see higher revenues this quarter after five major payer to authorize claims for payment for the PoNS Device, which might explain why they didn’t have much sales at all before. My average is currently above $9/share, and will try to average down when I have funds available before the jump!

0 · Reply

Crackberry Aug. 4 at 8:14 PM

$HSDT this trash wont move until it gets news and volume, management doesnt seem to care their stock is at all time lows so they wont help out. middle finger to this company stock

0 · Reply

Crackberry Aug. 4 at 8:14 PM

$HSDT garbage stock and dead money, moved on to better plays. in $BINI

0 · Reply

Hassan77 Aug. 4 at 7:31 PM

$HSDT Another day in HELLius POS dont you want $5???

0 · Reply

Lay1a Aug. 4 at 7:23 PM

$HSDT Absolutely no way $6 support will hold

0 · Reply

CumulativeChaser Aug. 4 at 10:19 AM

$PTHS $HSDT $APG $AIMD

0 · Reply

BitcoinBankers Aug. 4 at 8:25 AM

Ticker GYRO is exploding in pre-market!! Could GYRO be todays big squeeze?! news just released.. 700k shares float.. watchers on GYRO are growing very fast. Would not be surprised if GYRO is todays big 300% runner. 20$+ break could send her parabolic! $HSDT $MSTR $SOPA $TVGN pw

1 · Reply

Camelinvesting Aug. 3 at 1:54 PM

$HSDT needs opinions here on coming catalysts …share what you think is valuable

1 · Reply

Market Cap	83,000.00
Revenue (ttm)	520,000.00
Net Income (ttm)	-11.74M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-2,257.69%
Debt to Equity Ratio	0.00

Volume	33,500
Avg Vol	577,477
Day's Range	N/A - N/A
Shares Out	14,000.00
Stochastic %K	0%
Beta	0.73
Analysts	Hold
Price Target	$4.00